Summary
PROJECT SUMMARY Allergic asthma is a chronic inflammatory disease that often progresses from childhood to adulthood. Approximately 8% of the world population suffer from allergic asthma, making it one of the most common respiratory diseases. Allergic asthma is characterized by recurrent type 2 inflammation, mucus hyperplasia, and airway hyperreactivity. Current treatment strategies aim to temporally alleviate the symptoms of asthma attack and have no beneficial effect on disease progression. Recent studies have identified pathogenic T helper 2 resident memory cells in the lung (Th2-TRMs) as th
